Cleveland-based biopharmaceutical company Athersys Inc. (Nasdaq: ATHX) expects to produce gross proceeds of more than $50 million from an upcoming offering of its common stock.
Athersys said in a news released issued late Wednesday, April 15, that it has set a price of $2.25 per share for the offering of 22.25 million shares. The offering is expected to close on Monday, April 20.
Click here to read the complete story.
Story excerpt provided by Crain’s Cleveland Business.
Written by Scott Suttell.
Originally published April 16, 2020.